Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

US Patent 8048884 · Granted Nov 1, 2011

Estimated economic value: $58,453,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA2016
Oximes for treatment of peripheral and central nervous system exposure to acetyl2015
Reactivators of organophosphorous inhibited acetylcholinesterase2015
Oximes for treatment of peripheral and central nervous system exposure to acetyl2014
Purine compounds2014
Pyridinoylpiperidines as 5-HT1F agonists2014
Purine compounds used as CB2 agonists2014
Oximes for treatment of peripheral and central nervous system exposure to acetyl2014
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist2013
Purine compounds2012
Purine compounds2012
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor ant2012